Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
7
IRPSY Quote, Financials, Valuation and Earnings
Last price:
$9.94
Seasonality move
:
0%
Day range:
$9.94 - $9.94
52-week range:
$9.94 - $9.94
Dividend yield:
0.81%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
0.93x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$2B
Revenue:
$9.2B
EPS (TTM):
-$1.04
Analysts' Opinion
-
Consensus RatingIRPC PCL has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, IRPC PCL has an estimated downside of -- from its current price of $9.94.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $9.94.
Fair Value
-
According to the consensus of 0 analysts, IRPC PCL has -- downside to fair value with a price target of -- per share.
IRPSY vs. S&P 500
-
Over the past 5 trading days, IRPC PCL has overperformed the S&P 500 by 2.03% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
IRPC PCL does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
IRPC PCL revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter IRPC PCL reported revenues of $2.3B.
Earnings Growth
-
IRPC PCL has grown year-over-year earnings for 1 quarter straight. In the most recent quarter IRPC PCL reported earnings per share of -$0.69.
Enterprise value:
4.3B
EV / Invested capital:
0.94x
Price / LTM sales:
0.22x
EV / EBIT:
63.02x
EV / Revenue:
0.48x
PEG ratio (5yr expected):
-0.66x
EV / Free cash flow:
-43.86x
Price / Operating cash flow:
205.39x
Enterprise value / EBITDA:
76.61x
Gross Profit (TTM):
-$98.6M
Return On Assets:
-3.96%
Net Income Margin (TTM):
-2.38%
Return On Equity:
-10.02%
Return On Invested Capital:
-5.05%
Operating Margin:
-8.43%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $9.9B | $8.5B | $9B | $2.3B | $2.3B | |
| Gross Profit | $652.8M | -$1.7M | -$98.6M | $153.7M | -$133M | |
| Operating Income | $431.6M | -$196.9M | -$305.7M | $106.2M | -$193.6M | |
| EBITDA | $469.7M | $74.1M | $56.6M | $163M | -$89.6M | |
| Diluted EPS | $0.76 | -$0.91 | -$1.04 | $0.34 | -$0.69 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $1.9B | $2.1B | $1.8B | $1.7B | |
| Total Assets | $5.7B | $5.5B | $5.4B | $5.2B | $5.7B | |
| Current Liabilities | $1.6B | $1.3B | $1.4B | $1.4B | $1.7B | |
| Total Liabilities | $3.4B | $3B | $3.1B | $3.1B | $3.5B | |
| Total Equity | $2.3B | $2.5B | $2.3B | $2.1B | $2.2B | |
| Total Debt | $2.2B | $1.9B | $1.8B | $1.9B | $2.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $15M | $273.8M | $78.2M | $129.8M | -$12.2M | |
| Cash From Investing | -$170.8M | -$363.2M | -$174.7M | -$74.9M | -$13.6M | |
| Cash From Financing | -$73.5M | $51.7M | $93.8M | -$66.9M | -$1.6M | |
| Free Cash Flow | -$162.2M | -$85.5M | -$98.9M | $61.8M | -$26.5M | |
IRPSY
Sector
Market Cap
$2B
--
Price % of 52-Week High
100%
--
Dividend Yield
0.81%
--
Shareholder Yield
--
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0.81%
Annualized payout:
$0.09
Payout ratio:
-8.39%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$9.94
200-day SMA
Sell
Level
$9.94
Bollinger Bands (100)
Sell
Level
9.94 - 9.94
Chaikin Money Flow
Sell
Level
-200
20-day SMA
Sell
Level
$9.94
Relative Strength Index (RSI14)
Sell
Level
0.00
ADX Line
Neutral
Level
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$9.94
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-18
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2911)
Sell
CA Score
(Annual)
Level (-0.3106)
Sell
Beneish M-Score
(Annual)
Level (-2.0708)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.8886)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
IRPC PCL is a Thailand-based company. The Company is principally engaged in the petroleum and petrochemical business with its products being refinery, lubricant, olefins, aromatics, plastic resins, and other petrochemical products. The company operates in three reportable segments; the Petroleum products segment, which produces and sells refinery, lubricant, and asphalt; the petrochemical products segment, which produces and sells olefins, aromatics, and related products including special products; and Other business segments, includes divisions related to the Power plant, jetty, and other utilities. The majority of its revenue is derived from the Petroleum products segment.
Stock Forecast FAQ
In the current month, IRPSY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IRPSY average analyst price target in the past 3 months is --.
-
Where Will IRPC PCL Stock Be In 1 Year?
According to analysts, the consensus estimate is that IRPC PCL share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About IRPC PCL?
Analysts are divided on their view about IRPC PCL share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IRPC PCL is a Sell and believe this share price will rise from its current level to --.
-
What Is IRPC PCL's Price Target?
The price target for IRPC PCL over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IRPSY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for IRPC PCL is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IRPSY?
You can purchase shares of IRPC PCL via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IRPC PCL shares.
-
What Is The IRPC PCL Share Price Today?
IRPC PCL was last trading at $9.94 per share. This represents the most recent stock quote for IRPC PCL. Yesterday, IRPC PCL closed at $9.94 per share.
-
How To Buy IRPC PCL Stock Online?
In order to purchase IRPC PCL stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
